Your browser doesn't support javascript.
loading
Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients.
González, Luz M; Robles, Nicolás R; Mota-Zamorano, Sonia; Valdivielso, José M; González-Rodríguez, Laura; López-Gómez, Juan; Gervasini, Guillermo.
Afiliação
  • González LM; Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Av. Elvas S/N 06071, Badajoz, Spain.
  • Robles NR; Service of Nephrology, Badajoz University Hospital, Badajoz, Spain.
  • Mota-Zamorano S; ISCIII RICORS2040, Madrid, Spain.
  • Valdivielso JM; Department of Medical and Surgical Therapeutics, Medical School, University of Extremadura, Av. Elvas S/N 06071, Badajoz, Spain.
  • González-Rodríguez L; ISCIII RICORS2040, Madrid, Spain.
  • López-Gómez J; ISCIII RICORS2040, Madrid, Spain.
  • Gervasini G; Vascular and Renal Translational Research Group, UDETMA, IRBLleida, Lleida, Spain.
Sci Rep ; 13(1): 1253, 2023 01 23.
Article em En | MEDLINE | ID: mdl-36690661

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Nefroesclerose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dinoprostona / Nefroesclerose Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article